Fig. 5From: Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancersSurvival analysis of TNBC patients by expression of IgG4 + B cells, and inflammatory cytokines. Kaplan Meyer survival curves showing recurrence free and overall survival outcomes for patients with (a) high, intermediate or low densities of CD20, (b) IgG4 + or IgG4- B cells (c) high or low IL-10 expression (d) High or low IL-4 expressionBack to article page